BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15359571)

  • 1. Characterization and in vivo study of sustained-release formulation of human growth hormone using sodium hyaluronate.
    Hahn SK; Kim SJ; Kim MJ; Kim DH
    Pharm Res; 2004 Aug; 21(8):1374-81. PubMed ID: 15359571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a novel sustained release formulation of recombinant human growth hormone using sodium hyaluronate microparticles.
    Kim SJ; Hahn SK; Kim MJ; Kim DH; Lee YP
    J Control Release; 2005 May; 104(2):323-35. PubMed ID: 15907583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of recombinant human growth hormone variants from sodium hyaluronate-based sustained release formulation of rhGH under heat stress.
    Kim SJ; Kim CW
    Anal Biochem; 2015 Sep; 485():59-65. PubMed ID: 26093039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and Characterization of Sodium Hyaluronate Microparticle-Based Sustained Release Formulation of Recombinant Human Growth Hormone Prepared by Spray-Drying.
    Kim SJ; Kim CW
    J Pharm Sci; 2016 Feb; 105(2):613-622. PubMed ID: 26869423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
    J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical in vitro in vivo correlation of an hGH dextran microsphere formulation.
    Vlugt-Wensink KD; de Vrueh R; Gresnigt MG; Hoogerbrugge CM; van Buul-Offers SC; de Leede LG; Sterkman LG; Crommelin DJ; Hennink WE; Verrijk R
    Pharm Res; 2007 Dec; 24(12):2239-48. PubMed ID: 17929148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new sustained-release preparation of human growth hormone and its pharmacokinetic, pharmacodynamic and safety profile.
    Jostel A; Mukherjee A; Alenfall J; Smethurst L; Shalet SM
    Clin Endocrinol (Oxf); 2005 May; 62(5):623-7. PubMed ID: 15853836
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Khodaverdi E; Delroba K; Mohammadpour F; Khameneh B; Sajadi Tabassi SA; Tafaghodi M; Kamali H; Hadizadeh F
    Curr Drug Deliv; 2020; 17(2):174-183. PubMed ID: 31987020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Supercritical fluids processing of recombinant human growth hormone.
    Velega SP; Carlfors J
    Drug Dev Ind Pharm; 2005 Jan; 31(2):135-49. PubMed ID: 15773281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustained release of human growth hormone from PLGA solution depots.
    Brodbeck KJ; Pushpala S; McHugh AJ
    Pharm Res; 1999 Dec; 16(12):1825-9. PubMed ID: 10644069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Controlled release of bioactive recombinant human growth hormone from PLGA microparticles.
    Rafi M; Singh SM; Kanchan V; Anish CK; Panda AK
    J Microencapsul; 2010; 27(6):552-60. PubMed ID: 20690791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel sustained-release formulation of recombinant human growth hormone and its pharmacokinetic, pharmacodynamic and safety profiles.
    Wei Y; Wang Y; Kang A; Wang W; Ho SV; Gao J; Ma G; Su Z
    Mol Pharm; 2012 Jul; 9(7):2039-48. PubMed ID: 22663348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Recombinant Human Growth Hormone (rhGH) sustained-release microspheres by a low temperature aqueous phase/aqueous phase emulsion method.
    Kang J; Wu F; Cai Y; Xu M; He M; Yuan W
    Eur J Pharm Sci; 2014 Oct; 62():141-7. PubMed ID: 24907681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
    Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
    J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a sustained-release recombinant human growth hormone formulation.
    Kwak HH; Shim WS; Choi MK; Son MK; Kim YJ; Yang HC; Kim TH; Lee GI; Kim BM; Kang SH; Shim CK
    J Control Release; 2009 Jul; 137(2):160-5. PubMed ID: 19332090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sustained release growth hormone treatment during the rehabilitation of adult severe burn survivors.
    Kim JB; Cho YS; Jang KU; Joo SY; Choi JS; Seo CH
    Growth Horm IGF Res; 2016 Apr; 27():1-6. PubMed ID: 26843473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The stabilization and encapsulation of human growth hormone into biodegradable microspheres.
    Johnson OL; Jaworowicz W; Cleland JL; Bailey L; Charnis M; Duenas E; Wu C; Shepard D; Magil S; Last T; Jones AJ; Putney SD
    Pharm Res; 1997 Jun; 14(6):730-5. PubMed ID: 9210189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of methionine oxidation on the aggregation of recombinant human growth hormone.
    Mulinacci F; Poirier E; Capelle MA; Gurny R; Arvinte T
    Eur J Pharm Biopharm; 2013 Sep; 85(1):42-52. PubMed ID: 23958317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sustained release of human growth hormone (hGH) from collagen film and evaluation of effect on wound healing in db/db mice.
    Maeda M; Kadota K; Kajihara M; Sano A; Fujioka K
    J Control Release; 2001 Dec; 77(3):261-72. PubMed ID: 11733094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men.
    Hashimoto Y; Kamioka T; Hosaka M; Mabuchi K; Mizuchi A; Shimazaki Y; Tsunoo M; Tanaka T
    J Clin Endocrinol Metab; 2000 Feb; 85(2):601-6. PubMed ID: 10690862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.